Infectious Diseases 1302 - Infectious Disease Alert - Feb 01, 2009

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor, Stanford University School of Medicine
Section Editor, HIV

Hal B. Jenson, MD, FAAP
Professor of Pediatrics
Tufts University School of Medicine
Chief Academic Officer
Baystate Medical Center
Springfield, MA

Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Section Editor, Hospital Epidemiology,

Brian Blackburn, MD
Clinical Assistant Professor of Medicine
Division of Infectious Diseases and Geographic Medicine
Stanford University School of Medicine

Ellen Jo Baron, PhD, D(ABBM)
Professor of Pathology and Medicine
Stanford University Medical School Director
Clinical Microbiology Laboratory
Stanford University Medical Center

Subjects:

  • Universal Voluntary HIV Testing with Antiretroviral Therapy as a Strategy to Eliminate HIV Transmission
  • The Emergence of Pneumococcus Type 19A as the Major Cause of Mastoiditis in Children
  • Kingella kingae Infections in Children
  • Increased Incubation Time Increases the Yield of Culture in Prosthetic Joint Infection
  • Outbreak of Acute Schistosomiasis: Brief Exposure and Severe Morbidity
  • The Newest Methicillin-resistant Staphylococcus: MRSP
  • Decontamination in the ICU
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • present current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker's bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer Connie Price, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study.

Updates author Carol A. Kemper, MD, FACP, Associate Editors Brian Blackburn, Md, and Ellen Jo Baron, PhD, D(ABBM), report no financial relationships relevant to this field of study.

Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for Boehringer-Ingelheim and GSK.

Associate Editor Hal B. Jenson, MD, FAAP, is on the speaker's bureau for Merck.

Associate Editor Robert Muder, MD, does research for Aventis and Pharmacia.

Copyright 2009 AHC Media. All rights reserved.